In this study, we also reported miR-16 as significantly downregulated in NSCLC tumor tissues compared to the adjacent lung normal tissue counterparts, and we found that the levels of miR-16 are significantly reduced in KRAS-mutated primary NSCLC compared to KRAS-nonmutated NSCLC. This evidence concerns the gene KRAS and non-small cell lung carcinoma.